Reimbursement agencies in several countries now require health outcomes to be measured
in terms of quality-adjusted life-years (QALYs), leading to an immense increase in …

Universal health coverage (UHC) is at the center of current efforts to strengthen health
systems and improve the level and distribution of health and health services. This document …

Evidence-informed frameworks for cost-effective cancer prevention and management are
essential for delivering equitable outcomes and tackling the growing burden of cancer in all …

Abstract The World Health Organization's CHOosing Interventions that are Cost Effective
(WHO-CHOICE) thresholds for averting a disability-adjusted life-year of one to three times …

Background. Both ethical and economics concerns have been raised with respect to the
funding of drugs for rare diseases. This article reports both the cost-effectiveness of …

Healthcare systems in low-and middle-income countries face considerable population
healthcare needs with markedly fewer resources than those in higher income countries. The …

Background With continued roll-out of antiretroviral therapy (ART) in resource-limited
settings, evidence is emerging of increasing levels of transmitted drug-resistant HIV. We …

Canada has a unique system of public drug coverage and reimbursement characterized by
a centralized review agency that makes funding recommendations along with decentralized …

Background New evidence on the clinical effectiveness of acupuncture plus usual care
(acupuncture) and counselling plus usual care (counselling) for patients with depression …

This report by the WHO Consultative Group on Equity and Universal Health Coverage
addresses how countries can make fair progress towards the goal of universal coverage. It …